Literature DB >> 21146822

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

Hiroshi Mabuchi1, Atsushi Nohara, Tohru Noguchi, Junji Kobayashi, Masa-Aki Kawashiri, Hayato Tada, Chiaki Nakanishi, Mika Mori, Masakazu Yamagishi, Akihiro Inazu, Junji Koizumi.   

Abstract

AIM: Familial hypercholesterolemia (FH) is caused by mutations of FH genes, i.e. LDL-receptor (LDLR), PCSK9 and apolipoprotein B (ApoB) gene. We evaluated the usefulness of DNA analysis for the diagnosis of homozygous FH (homo-FH), and studied the frequency of FH in the Hokuriku district of Japan.
METHODS: Twenty-five homo-FH patients were recruited. LDLR mutations were identified using the Invader assay method. Mutations in PCSK9 were detected by PCR-SSCP followed by direct sequence analysis.
RESULTS: We confirmed 15 true homozygotes and 10 compound heterozygotes for LDLR mutations. Three types of double heterozygotes for LDLR and PCSK9 were found. No FH patients due to ApoB mutations were found. The incidences of homo-FH and hetero-FH in the Hokuriku district were 1/171,167 and 1/208, respectively.
CONCLUSIONS: Our observations underlined the value of FH gene analysis in diagnosing homo-FH and confirmed extraordinarily high frequency of FH in the Hokuriku district of Japan.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146822     DOI: 10.1016/j.atherosclerosis.2010.11.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

Review 1.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

Review 2.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 3.  Genetics of familial hypercholesterolemia.

Authors:  Ariel Brautbar; Emili Leary; Kristen Rasmussen; Don P Wilson; Robert D Steiner; Salim Virani
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 4.  Personalized medicine for cardiovascular diseases.

Authors:  Hayato Tada; Noboru Fujino; Akihiro Nomura; Chiaki Nakanishi; Kenshi Hayashi; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Hum Genet       Date:  2020-08-08       Impact factor: 3.172

Review 5.  Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia.

Authors:  Alpo Vuorio; Matti J Tikkanen; Petri T Kovanen
Journal:  Vasc Health Risk Manag       Date:  2014-05-06

6.  Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method.

Authors:  Hayato Tada; Masa-Aki Kawashiri; Atsushi Nohara; Akihiro Inazu; Hiroshi Mabuchi; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Pract Lab Med       Date:  2015-03-13

Review 7.  Homozygous Familial Hypercholesterolemia.

Authors:  Atsushi Nohara; Hayato Tada; Masatsune Ogura; Sachiko Okazaki; Koh Ono; Hitoshi Shimano; Hiroyuki Daida; Kazushige Dobashi; Toshio Hayashi; Mika Hori; Kota Matsuki; Tetsuo Minamino; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-18       Impact factor: 4.928

Review 8.  Familial hypercholesterolemia in Southeast and East Asia.

Authors:  Candace L Jackson; Magdi Zordok; Iftikhar J Kullo
Journal:  Am J Prev Cardiol       Date:  2021-02-12

9.  Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey.

Authors:  S Walzer; K Travers; S Rieder; E Erazo-Fischer; D Matusiewicz
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-03

10.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Authors:  Jing Pang; Miao Hu; Jie Lin; Takashi Miida; Hapizah M Nawawi; Jeong Euy Park; Xue Wu; Anis S Ramli; Ngoc Thanh Kim; See Kwok; Lourdes E Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Handrean Soran; Shizuya Yamashita; Brian Tomlinson; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.